z-logo
Premium
Crosslinking reaction mechanism of diisopropyl xanthogen polysulfide accelerator in bromobutyl elastomer for medical device applications
Author(s) -
Ohbi D. S.,
Purewal T. S.,
Shah T.,
Siores E.
Publication year - 2007
Publication title -
journal of applied polymer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.575
H-Index - 166
eISSN - 1097-4628
pISSN - 0021-8995
DOI - 10.1002/app.27618
Subject(s) - polysulfide , curing (chemistry) , elastomer , reaction mechanism , polymer chemistry , thermogravimetric analysis , natural rubber , sulfide , vulcanization , infrared spectroscopy , chemistry , materials science , carbon disulfide , organic chemistry , catalysis , electrode , electrolyte
The use of an accelerator based on diisopropyl xanthogen polysulfide (DIXP) to formulate bromobutyl elastomer (BIIR‐DIXP) compositions for sealing medical devices was published in the Journal of Applied Polymer Science (Ohbi, D. S.; Pureval, T. S.; Shah, T.; Siores, E. 2007, 106, 526). In this publication, a reaction scheme for the DIXP accelerator in situ with BIIR is proposed. It is based on the evolved volatile chemical species determined during the curing reaction of BIIR‐DIXP composition, and is formulated in the light of generally accepted mechanism of crosslinking elastomers using sulfur‐based accelerators. The volatile chemical species were determined using coupled thermogravimetric infrared analysis ( TGA‐IR) and head space gas chromatography mass spectroscopy (GC‐MS) analysis. The main volatiles evolved during the curing reaction were carbonyl sulfide, carbon disulfide, and isopropyl bromide. These are considered to be associated with the formation of the active rubber‐bound DIXP sulfurating species required for the crosslinking reaction. Analysis of the acetone extract of cured BIIR‐DIXP also showed that the DIXP is totally consumed during the cure reaction, and the formulation is largely free of cure reaction byproducts. © 2007 Wiley Periodicals, Inc. J Appl Polym Sci, 2008

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here